UK watchdog fines GSK $54 mln over 'pay-for-delay' drug deals
February 12, 2016 at 02:18 AM EST
LONDON, Feb 12 (Reuters) - Britain's competition body said on Friday it had fined GlaxoSmithKline 37.6 million pounds ($54.42 million) for market abuse in striking deals to delay the launch of generic copies of its antidepressant Seroxat.
